Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Retained Earnings (2020 - 2026)

Valneva SE (VALN) posted Retained Earnings of $99.5 million for Q1 2026, up 2.6% sequentially from $97.0 million in Q4 2025, and up 23.76% YoY from $80.4 million in Q1 2025.

Analysis

Valneva SE (VALN) Retained Earnings (2020 - 2026) Analysis & Trends

Valneva SE has reported Retained Earnings for 8 years, with the latest figure at $99.5 million in Q1 2026.

  • Quarterly Retained Earnings rose 23.76% year-over-year to $99.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99.5 million (up 23.76% YoY) and the FY2025 annual result came in at $97.0 million, up 116.24% from the prior year.
  • Retained Earnings rose to $99.5 million in Q1 2026 per VALN's latest filing, from $97.0 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $99.5 million in Q1 2026 and troughed at -$589.5 million in Q4 2024.
  • A 5-year average of $34.7 million and a median of $70.0 million in 2023 frame the typical range for Retained Earnings.
  • The sharpest annual moves came in 2022 and 2024: Retained Earnings jumped 121.1% in 2022, then sank 941.81% in 2024.
  • Over 5 years, Retained Earnings stood at $56.4 million in 2022, then increased by 24.23% to $70.0 million in 2023, then sank by 941.81% to -$589.5 million in 2024, then soared by 116.45% to $97.0 million in 2025, then gained by 2.6% to $99.5 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered $99.5 million, $97.0 million, and $95.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn -789.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -789.38 Mn
Mar 31, 2026 -795.08 Mn
Dec 31, 2025 -656.44 Mn
Sep 30, 2025 -659.26 Mn
Jun 30, 2025 -638.34 Mn
Mar 31, 2025 -593.19 Mn
Dec 31, 2024 -589.52 Mn
Sep 30, 2024 -605.87 Mn
Jun 30, 2024 -594.10 Mn
Mar 31, 2024 -599.33 Mn
Dec 31, 2023 -484.45 Mn
Sep 30, 2023 -490.14 Mn
Jun 30, 2023 -490.29 Mn
Mar 31, 2023 -483.28 Mn
Dec 31, 2022 -313.19 Mn
Sep 30, 2022 -309.51 Mn
Jun 30, 2022 -327.56 Mn
Dec 31, 2021 -267.17 Mn
Dec 31, 2020 -201.68 Mn